These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 20959468

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer.
    Wunderlich A, Fischer M, Schlosshauer T, Ramaswamy A, Greene BH, Brendel C, Doll D, Bartsch D, Hoffmann S.
    Cancer Sci; 2011 Apr; 102(4):762-8. PubMed ID: 21214672
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Rapid histamine-induced neutrophil recruitment is sphingosine kinase-1 dependent.
    Sun WY, Abeynaike LD, Escarbe S, Smith CD, Pitson SM, Hickey MJ, Bonder CS.
    Am J Pathol; 2012 Apr; 180(4):1740-50. PubMed ID: 22322303
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer.
    Chua CW, Lee DT, Ling MT, Zhou C, Man K, Ho J, Chan FL, Wang X, Wong YC.
    Int J Cancer; 2005 Dec 20; 117(6):1039-48. PubMed ID: 15986440
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.
    Hu Y, Lee X, Ji B, Guckian K, Apicco D, Pepinsky RB, Miller RH, Mi S.
    Mol Cell Neurosci; 2011 Sep 20; 48(1):72-81. PubMed ID: 21740973
    [Abstract] [Full Text] [Related]

  • 50. Sphingosine mediates FTY720-induced apoptosis in LLC-PK1 cells.
    Lee WJ, Yoo HS, Suh PG, Oh S, Lim JS, Lee YM.
    Exp Mol Med; 2004 Oct 31; 36(5):420-7. PubMed ID: 15557814
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.
    Strader CR, Pearce CJ, Oberlies NH.
    J Nat Prod; 2011 Apr 25; 74(4):900-7. PubMed ID: 21456524
    [Abstract] [Full Text] [Related]

  • 53. Fingolimod impedes Schwann cell-mediated myelination: implications for the treatment of immune neuropathies?
    Köhne A, Stettner M, Jangouk P, Dehmel T, Hartung HP, Lehmann HC, Kieseier BC.
    Arch Neurol; 2012 Oct 25; 69(10):1280-9. PubMed ID: 22751954
    [Abstract] [Full Text] [Related]

  • 54. FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
    Moon H, Chon J, Joo J, Kim D, In J, Lee H, Park J, Choi J.
    Diabetes Metab Res Rev; 2013 Jan 25; 29(1):19-24. PubMed ID: 22936676
    [Abstract] [Full Text] [Related]

  • 55. Distinct properties of circulating CD8+ T cells in FTY720-treated patients with multiple sclerosis.
    Johnson TA, Lapierre Y, Bar-Or A, Antel JP.
    Arch Neurol; 2010 Dec 25; 67(12):1449-55. PubMed ID: 21149809
    [Abstract] [Full Text] [Related]

  • 56. Molecular targets of FTY720 (fingolimod).
    Pitman MR, Woodcock JM, Lopez AF, Pitson SM.
    Curr Mol Med; 2012 Dec 25; 12(10):1207-19. PubMed ID: 22834825
    [Abstract] [Full Text] [Related]

  • 57. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases.
    Billich A, Bornancin F, Dévay P, Mechtcheriakova D, Urtz N, Baumruker T.
    J Biol Chem; 2003 Nov 28; 278(48):47408-15. PubMed ID: 13129923
    [Abstract] [Full Text] [Related]

  • 58. Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
    Kowarik MC, Pellkofer HL, Cepok S, Korn T, Kümpfel T, Buck D, Hohlfeld R, Berthele A, Hemmer B.
    Neurology; 2011 Apr 05; 76(14):1214-21. PubMed ID: 21464424
    [Abstract] [Full Text] [Related]

  • 59. Differential responses of human microglia and blood-derived myeloid cells to FTY720.
    Durafourt BA, Lambert C, Johnson TA, Blain M, Bar-Or A, Antel JP.
    J Neuroimmunol; 2011 Jan 05; 230(1-2):10-6. PubMed ID: 20826007
    [Abstract] [Full Text] [Related]

  • 60. Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia.
    Pfeilschifter W, Czech-Zechmeister B, Sujak M, Mirceska A, Koch A, Rami A, Steinmetz H, Foerch C, Huwiler A, Pfeilschifter J.
    Biochem Biophys Res Commun; 2011 Sep 23; 413(2):212-7. PubMed ID: 21872577
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.